Previous PAIS cohorts (6, 8, 16, 17) have described the occurrence of gynecomastia in PAIS but have not have explored the details as comprehensively in terms of clinical and biochemical aspects and the relationship with the AR variant as in the current study. The gene discussed is AR; the disease is Gynecomastia.